Skip to main content

Table 2 Study population and tumor characteristics by ER status in the NHS and the NHSII

From: Alcohol consumption and breast tumor gene expression

 

ER+ tumors

N = 471

ER- tumors

N = 127

 

Mean

SD

Mean

SD

Age at diagnosis, years

61.4

9.6

59.1

8.9

BMI at diagnosis, kg/m2

26.0

5.0

26.1

5.1

Parity

2.6

1.8

2.9

1.8

Recent alcohol, g/day

6.5

11.7

5.8

10.0

Cumulative average alcohol, g/day

6.4

9.5

5.5

8.2

 

N

%

N

%

First-degree family history

79

16.8

16

12.6

Year of diagnosis

 1990‒1999

251

53.3

91

71.7

 2000 − 2004

182

38.6

26

20.5

 2005‒2009

38

8.1

10

7.9

Tumor size

 0.1‒2.0 cm

365

77.5

68

53.5

 2.1‒4.0 cm

75

15.9

46

36.2

 > 4.0 cm

23

4.9

7

5.5

 Unknown

8

1.7

6

4.7

Lymph node involvement

 None

349

74.1

95

74.8

 1‒3 positive nodes

85

18.0

22

17.3

 > 3 positive nodes

33

7.0

8

6.3

 Metastatic at diagnosis

4

0.8

1

0.8

 Unknown

0

0

1

0.8

Grade

 Well-differentiated

124

26.3

6

4.7

 Moderately differentiated

243

51.6

35

27.6

 Poorly differentiated

89

18.9

67

52.8

 Unknown

15

3.2

19

15.0

Stagea

 I

305

64.8

57

44.9

 II

122

25.9

59

46.5

 III

40

8.5

9

7.1

 IV

4

0.8

1

0.8

 Unknown

0

0

1

0.8

  1. ER estrogen receptor, NHS Nurses’ Health Study, BMI body mass index
  2. aStaging was based on tumor size and lymph node involvement